T-VEC has been postulated to potentially play a role in altering tumor microenvironments, further proposing T-VEC being synergistic or improving the efficacy of other treatment modalities like anti-PD-1 therapy [112,113,114]. The gene discussed is PDCD1; the disease is neoplasm.